Skip to content

Zataria multiflora for the treatment of functional dyspepsia

Zataria multiflora as a Iranian traditional compound for the treatment of functional dyspepsia, add-on double blind randomized controlled trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20231109060005N1
Enrollment
60
Registered
2024-12-30
Start date
2024-12-30
Completion date
Unknown
Last updated
2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional dyspepsia. Functional dyspepsia

Interventions

Intervention 1: Intervention group: each sachet contains 5 grams of zataria powder and 5 grams of sugar. The patient consumes dry powder after each meal.The method of taking the drug will be in the fo

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients with one of the symptoms of ROME IV dyspepsia criteria lasting at least 6 months and the patient should have these symptoms at least 3 days a week for 3 months: Complaining of postprandial fullness OR complaining of heart burn OR complaining of stomach pain OR complaining of premature satiety willingness to participate in the study by signing the informed consent form

Exclusion criteria

Exclusion criteria: Allergy to zataria and Placebo (corn starch) Diagnosis of organic indigestion before or during the study taking anticoagulants such as warfarin, Plavix, aspirin and other drugs that may interact with zataria or have a possible positive or negative effect on functional indigestion Pregnancy or schedule for it during the study period breastfeeding

Design outcomes

Primary

MeasureTime frame
Postprandial distress and pain score in Gastrointestinal Symptom Rating Scale (GSRS) questionnaire and Single dyspepsia symptom scale (SDS). Timepoint: Before intervention and 2 weeks after intervention. Method of measurement: Gastrointestinal Symptom Rating Scale (GSRS) questionnaire and Single dyspepsia symptom scale (SDS).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMilad Safari

Shiraz University of Medical Sciences

milads@iran.ir+98 917 808 9354

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026